Streetbeat News

Stock Prices

VSTS

Elis has terminated discussions with Vestis and UniFirst regarding potential US market entry, citing financial discipline. Vestis shares moved lower following the announcement.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:17 pm

CAPR

Capricor Therapeutics will present long-term data from its HOPE-2 open-label extension study at the 2024 World Muscle Society Congress. The study focuses on the safety and efficacy of deramiocel for treating Duchenne muscular dystrophy.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:15 pm

MTSI

MACOM Technology Solutions (NYSE:MTSI) has seen a 5.17% increase in its short percent of float, now at 6.31%. This is higher than its peers' average of 4.34%. The rise in short interest suggests bearish sentiment, but it could also indicate a potential bullish opportunity if the stock price rises.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 1:15 pm

WYNN

Wynn Resorts (NYSE:WYNN) has seen a 5.8% increase in its short percent of float, now at 4.56%. This indicates a bearish sentiment among investors, although its short interest is below the peer group average of 4.80%.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 1:15 pm

AEP

American Electric Power (AEP) has seen a 10.2% increase in its short percent of float, now at 1.62% of available shares. This indicates a rise in bearish sentiment, although AEP's short interest is below the peer average of 2.21%.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 1:15 pm

UBER

Uber Technologies Inc. (NYSE:UBER) stock is experiencing short-term bearish signals, trading below its eight-day and 20-day SMAs, but remains above its 50-day and 200-day SMAs, indicating long-term bullish potential. Despite promising partnerships and technical indicators, investors are cautious due to mixed short-term signals.

Portfolio Pulse from Surbhi Jain

October 04, 2024 | 1:12 pm

LYEL

Lyell Immunopharma's stock is rising following the announcement that three of its abstracts on clinical product candidates and anti-exhaustion technology will be presented at the Society for Immunotherapy of Cancer's annual meeting.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:12 pm

SGD

SG DevCo has announced a 1-for-20 reverse stock split effective October 8. This corporate action is aimed at increasing the stock price by reducing the number of shares outstanding.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:03 pm

LYEL

Lyell Immunopharma announced that three abstracts on its clinical product candidates and anti-exhaustion technology will be presented at the 39th Annual Meeting of the Society for Immunotherapy of Cancer. This includes data from the LYL797 Phase 1 trial showing promising results in solid tumor treatment.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:03 pm

CADL

Candel Therapeutics is set to present preclinical data on its therapeutic candidate CAN-3110 for melanoma at the SITC 2024 Annual Meeting. The presentation will focus on the potential of CAN-3110 in treating Ras-Raf pathway altered melanoma.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:02 pm